Neonatal HSV-1 diversity greater between patients than within patients
-
By
-
Kathryn Wighton
-
August 12, 2026
-
5 min
By
Kathryn Wighton
August 12, 2026
by Kathryn Wighton
August 12, 2026
Patients who switched from daily antiretroviral therapy maintained virologic suppression in two phase 3 trials.
July 23, 2026
Molecular testing identified Encephalitozoon hellem in a 9-year-old orthokeratology lens wearer after conventional treatment failed.
September 16, 2026
"Many of us [clinicians] default to using single-tablet regimens."
by Alun Evans
August 26, 2026